Cytotoxic biflavonoids from Selaginella willdenowii

Area of Science:

• Phytochemistry
• Natural Products Chemistry
• Pharmacology

Background:

• Selaginella species are a rich source of bioactive natural products.
• Biflavonoids are a class of compounds known for diverse biological activities.
• Cytotoxicity of plant-derived compounds is a key area in cancer research.

Purpose of the Study:

• To isolate and identify bioactive compounds from Selaginella willdenowii leaves.
• To evaluate the cytotoxic potential of isolated compounds against human cancer cell lines.
• To characterize any novel compounds discovered.

Main Methods:

• Bioactivity-guided fractionation of plant extracts.
• Isolation and purification of chemical constituents using chromatographic techniques.
• Structure elucidation of compounds using spectroscopic methods (NMR, MS).
• Cytotoxicity assays against a panel of human cancer cell lines.

Main Results:

• Three known cytotoxic biflavonoids were identified: 4",7"-di-O-methylamentoflavone, isocryptomerin, and 7"-O-methylrobustaflavone.
• A new dihydrobiflavone, 2",3"-dihydroisocryptomerin, was isolated and characterized.
• Several non-cytotoxic biflavonoids were also obtained, including amentoflavone, bilobetin, and robustaflavone.
• The isolated compounds showed significant cytotoxic effects against various human cancer cell lines.

Conclusions:

• Selaginella willdenowii leaves contain biflavonoids with significant cytotoxic activity against cancer cells.
• The newly identified dihydrobiflavone warrants further investigation for its therapeutic potential.
• These findings highlight the potential of Selaginella species as a source for novel anticancer agents.